Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ARMO BioSciences, Inc. (ARMO) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/22/2018 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of ARMO BioSciences, Inc.",
"Amended and Restated Bylaws of ARMO BioSciences, Inc."
05/10/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Agreement and Plan of Merger by and between Eli Lilly and Company, Bluegill Acquisition Corporation and ARMO BioSciences, Inc.",
"Tender and Support Agreement, by and among Eli Lilly and Company, Bluegill Acquisition Corporation and certain stockholders of ARMO BioSciences, Inc",
"Lilly Announces Agreement To Acquire ARMO BioSciences"
04/02/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : April 2, 2018 ARMO BIOSCIENCES, INC. Delaware 001-38345 27-3454138 575 Chesapeake Drive Redwood City, CA 94063 94063 779-5075 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 ...",
"ARMO BioSciences Reports FY 2017 Financial Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy